Free Trial

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

Quest Diagnostics logo
$172.69 -1.28 (-0.74%)
Closing price 03:59 PM Eastern
Extended Trading
$172.67 -0.02 (-0.01%)
As of 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Earnings Summary

Quest Diagnostics posted Q1 2025 earnings on April 22, 2025, reporting an EPS of $2.21, which topped analysts' consensus estimates of $2.15 by $0.06. Quarterly revenue was reported to be $2.65 billion, above the consensus estimate of $2.63 billion. With a trailing EPS of $7.91 and a P/E Ratio of 21.83, Quest Diagnostics' earnings are expected to grow 8.14% next year, from $9.70 to $10.49 per share.

Upcoming Q2
Earnings Date
Jul. 22Before Market OpensEstimated
Consensus EPS
(Apr. 22)
$2.15
Actual EPS
(Apr. 22)
$2.21 Beat By $0.06
Actual Revenue
(Apr. 22)
$2.65B

Q1 2025 Earnings Resources

DGX Upcoming Earnings

Quest Diagnostics' Q2 2025 earnings is scheduled for Tuesday, July 22, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Quest Diagnostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20253$2.11$2.19$2.16
Q2 20253$2.43$2.56$2.51
Q3 20253$2.50$2.53$2.51
Q4 20253$2.40$2.42$2.41
FY 2025 12 $9.44 $9.70 $9.59
Q1 20262$2.36$2.39$2.38
Q2 20262$2.68$2.93$2.81
Q3 20262$2.70$2.73$2.72
Q4 20262$2.48$2.68$2.58
FY 2026 8 $10.22 $10.73 $10.48
Q1 20271$2.62$2.62$2.62

Quest Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/22/2025
(Estimated)
-------
4/22/2025Q1 2025$2.15$2.21+$0.06$1.94$2.63B$2.65B
1/30/2025Q4 2024$2.19$2.23+$0.04$1.95$2.58B-
10/22/2024Q3 2024$2.26$2.30+$0.04$2.61$2.43B$2.49B
7/23/2024Q2 2024$2.31$2.35+$0.04$2.67$2.39B$2.40B
4/23/2024Q1 2024$1.86$2.04+$0.18$2.36$2.29B$2.37B
2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25B$2.29B
10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27B$2.30B
7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25B$2.34B

Quest Diagnostics Earnings - Frequently Asked Questions

Quest Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 22nd, 2025 based off last year's report dates. Learn more on DGX's earnings history.

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.21 earnings per share (EPS) to beat the analysts' consensus estimate of $2.15 by $0.06. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

The conference call for Quest Diagnostics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Quest Diagnostics' latest earnings report can be read online.
Read Transcript

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.87 billion.

Quest Diagnostics (NYSE:DGX) has a recorded net income of $871 million. DGX has generated $7.91 earnings per share over the last four quarters.

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 21.83 and a forward price-to-earnings ratio of 17.80. The price/earnings-to-growth ratio is 2.47.

Quest Diagnostics' earnings are expected to grow from $9.70 per share to $10.49 per share in the next year, which is a 8.14% increase.

More Earnings Resources from MarketBeat



This page (NYSE:DGX) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners